Role of retinoic acid in the modulation of benzo(a)pyrene-DNA adducts in human hepatoma cells: Implications for cancer prevention

Toxicology and Applied Pharmacology

Volumn 249, Issue 3, 2010, Pages 224-230

  Zhou, Guo Dong ^a,c   Richardson, Molly ^a   Fazili, Inayat S ^b   Wang, Jianbo ^c   Donnelly, Kirby C ^a   Wang, Fen ^c   Amendt, Brad ^c   Moorthy, Bhagavatula ^b  

^a TEXAS A AND M UNIVERSITY   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

Author keywords

32P Postlabeling assay; Apoptosis; Benzo(a)pyrene; DNA adducts; DNA repair; HepG2

Indexed keywords

BENZO[A]PYRENE; CARCINOGEN; CYTOCHROME P450 1A1; DIMETHYL SULFOXIDE; RETINOIC ACID;

APOPTOSIS; ARTICLE; CANCER PREVENTION; CARCINOGEN DNA INTERACTION; CELL DAMAGE; CELL STRAIN HEPG2; CONTROLLED STUDY; DNA ADDUCT; DNA REPAIR; HEPATOMA CELL; HUMAN; HUMAN CELL; HYPOTHESIS; LIVER CARCINOGENESIS;

ANTICARCINOGENIC AGENTS; BENZO(A)PYRENE; CARCINOMA, HEPATOCELLULAR; CYTOCHROME P-450 CYP1A1; DNA ADDUCTS; DNA REPAIR; HEP G2 CELLS; HUMANS; LIVER NEOPLASMS; TRETINOIN;

EID: 78149412193     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2010.09.019     Document Type: Article

References (63)

1. Arce F., Gatjens-Boniche O., Vargas E., Valverde B., Diaz C. Apoptotic events induced by naturally occurring retinoids ATRA and 13-cis retinoic acid on human hepatoma cell lines Hep3B and HepG2. Cancer Lett. 2005, 229:271-281.
2. Bogos K., Renyi-Vamos F., Kovacs G., Tovari J., Dome B. Role of retinoic receptors in lung carcinogenesis. J. Exp. Clin. Cancer Res. 2008, 27:18.
3. Braithwaite E., Wu X., Wang Z. Repair of DNA lesions induced by polycyclic aromatic hydrocarbons in human cell-free extracts: involvement of two excision repair mechanisms in vitro. Carcinogenesis 1998, 19:1239-1246.
4. Chang W.L., Chapkin R.S., Lupton J.R. Fish oil blocks azoxymethane-induced rat colon tumorigenesis by increasing cell differentiation and apoptosis rather than decreasing cell proliferation. J. Nutr. 1998, 128:491-497.
5. David M., Hodak E., Lowe N.J. Adverse effects of retinoids. Med. Toxicol. Adverse Drug Exp. 1988, 3:273-288.
6. Dennis T., Fanous M., Mousa S. Natural products for chemopreventive and adjunctive therapy in oncologic disease. Nutr. Cancer 2009, 61:587-597.
7. Ellis R.E., Yuan J.Y., Horvitz H.R. Mechanisms and functions of cell death. Annu. Rev. Cell Biol. 1991, 7:663-698.
8. Gottschling S., Reinhard H., Pagenstecher C., Kruger S., Raedle J., Plotz G., Henn W., Buettner R., Meyer S., Graf N. Hypothesis: possible role of retinoic acid therapy in patients with biallelic mismatch repair gene defects. Eur. J. Pediatr. 2008, 167:225-229.
9. Green D.R., Martin S.J. The killer and the executioner: how apoptosis controls malignancy. Curr. Opin. Immunol. 1995, 7:694-703.
10. Guggenheim E.R., Xu D., Zhang C.X., Chang P.V., Lippard S.J. Photoaffinity isolation and identification of proteins in cancer cell extracts that bind to platinum-modified DNA. Chembiochem 2009, 10:141-157.
11. Gupta R.C. Nonrandom binding of the carcinogen N-hydroxy-2-acetylaminofluorene to repetitive sequences of rat liver DNA in vivo. Proc. Natl Acad. Sci. USA 1984, 81:6943-6947.
12. Hang B. Repair of exocyclic DNA adducts: rings of complexity. Bioessays 2004, 26:1195-1208.
13. Hecht S.S. Tobacco carcinogens, their biomarkers and tobacco-induced cancer. Nat. Rev. 2003, 3:733-744.
14. Hong M.Y., Chapkin R.S., Barhoumi R., Burghardt R.C., Turner N.D., Henderson C.E., Sanders L.M., Fan Y.Y., Davidson L.A., Murphy M.E., Spinka C.M., Carroll R.J., Lupton J.R. Fish oil increases mitochondrial phospholipid unsaturation, upregulating reactive oxygen species and apoptosis in rat colonocytes. Carcinogenesis 2002, 23:1919-1925.
15. Hong M.Y., Lupton J.R., Morris J.S., Wang N., Carroll R.J., Davidson L.A., Elder R.H., Chapkin R.S. Dietary fish oil reduces O6-methylguanine DNA adduct levels in rat colon in part by increasing apoptosis during tumor initiation. Cancer Epidemiol. Biomark. Prev. 2000, 9:819-826.
16. Hong W.K., Lippman S.M. Cancer chemoprevention. J. Natl Cancer Inst. 1995, 49-53.
17. Jeffrey A.M., Weinstein I.B., Jennette K.W., Grzeskowiak K., Nakanishi K., Harvey R.G., Autrup H., Harris C. Structures of benzo(a)pyrene-nucleic acid adducts formed in human and bovine bronchial explants. Nature 1977, 269:348-350.
18. Josephy P., Mannervik B. Oncogenes, tumor suppress genes, and mutations in cancer cells. Molecular Toxicology 2006, 155-190. Oxford University Press, New York. Second edition.
19. Knasmuller S., Parzefall W., Sanyal R., Ecker S., Schwab C., Uhl M., Mersch-Sundermann V., Williamson G., Hietsch G., Langer T., Darroudi F., Natarajan A.T. Use of metabolically competent human hepatoma cells for the detection of mutagens and antimutagens. Mutat. Res. 1998, 402:185-202.
20. Kondraganti S.R., Fernandez-Salguero P., Gonzalez F.J., Ramos K.S., Jiang W., Moorthy B. Polycyclic aromatic hydrocarbon-inducible DNA adducts: evidence by 32P-postlabeling and use of knockout mice for Ah receptor-independent mechanisms of metabolic activation in vivo. Int. J. Cancer 2003, 103:5-11.
21. Lee Y.W., Park H.J., Son K.W., Hennig B., Robertson L.W., Toborek M. 2,2μ,4,6,6μ-Pentachlorobiphenyl (PCB 104) induces apoptosis of human microvascular endothelial cells through the caspase-dependent activation of CREB. Toxicol. Appl. Pharmacol. 2003, 189:1-10.
22. Lippman S.M., Hawk E.T. Cancer prevention: from 1727 to milestones of the past 100years. Cancer Res. 2009, 69:5269-5284.
23. Lu X.P., Fanjul A., Picard N., Pfahl M., Rungta D., Nared-Hood K., Carter B., Piedrafita J., Tang S., Fabbrizio E., Pfahl M. Novel retinoid-related molecules as apoptosis inducers and effective inhibitors of human lung cancer cells in vivo. Nat. Med. 1997, 3:686-690.
24. Mabon N., Moorthy B., Randerath E., Randerath K. Monophosphate 32P-postlabeling assay of DNA adducts from 1,2:3,4-diepoxybutane, the most genotoxic metabolite of 1,3-butadiene: in vitro methodological studies and in vivo dosimetry. Mutat. Res. 1996, 371:87-104.
25. McCarty K.M., Santella R.M., Steck S.E., Cleveland R.J., Ahn J., Ambrosone C.B., North K., Sagiv S.K., Eng S.M., Teitelbaum S.L., Neugut A.I., Gammon M.D. PAH-DNA adducts, cigarette smoking, GST polymorphisms, and breast cancer risk. Environ. Health Perspect. 2009, 117:552-558.
26. Metzstein M.M., Stanfield G.M., Horvitz H.R. Genetics of programmed cell death in C. elegans: past, present and future. Trends Genet. 1998, 14:410-416.
27. Mohamad N., Gutierrez A., Nunez M., Cocca C., Martin G., Cricco G., Medina V., Rivera E., Bergoc R. Mitochondrial apoptotic pathways. Biocell 2005, 29:149-161.
28. Moorthy B. Persistent expression of 3-methylcholanthrene-inducible cytochromes P4501A in rat hepatic and extrahepatic tissues. J. Pharmacol. Exp. Ther. 2000, 294:313-322.
29. Moorthy B., Randerath K. Pentachlorophenol enhances 9-hydroxybenzo [a] pyrene-induced hepatic DNA adduct formation in vivo and inhibits microsomal epoxide hydrolase and glutathione S-transferase activities in vitro: likely inhibition of epoxide detoxication by pentachlorophenol. Arch. Toxicol. 1996, 70:696-703.
30. Mrass P., Rendl M., Mildner M., Gruber F., Lengauer B., Ballaun C., Eckhart L., Tschachler E. Retinoic acid increases the expression of p53 and proapoptotic caspases and sensitizes keratinocytes to apoptosis: a possible explanation for tumor preventive action of retinoids. Cancer Res. 2004, 64:6542-6548.
31. Natarajan A.T., Darroudi F. Use of human hepatoma cells for in vitro metabolic activation of chemical mutagens/carcinogens. Mutagenesis 1991, 6:399-403.
32. Noy N. Between death and survival: retinoic acid in regulation of apoptosis. Annu. Rev. Nutr. 2010, 30:201-217.
33. Parkinson A. Carsarett and Doull's Toxicology: The Basic Science of Poisons. Biotransformation of xenobiotics 2001, 133. C.D. Klaassen (Ed.).
34. Phillips, T. D., Smith, M.R., Zhou, G.D., Donnelly, K.C. The relationships between levels of DNA adducts and tumor incidence in different tissues of B6C3F1 male mice treated with benzo(a)pyrene and a reconstituted PAH mixture (unpublished data).
35. Randerath E., Avitts T.A., Reddy M.V., Miller R.H., Everson R.B., Randerath K. Comparative 32P-analysis of cigarette smoke-induced DNA damage in human tissues and mouse skin. Cancer Res. 1986, 46:5869-5877.
36. Randerath E., Miller R.H., Mittal D., Avitts T.A., Dunsford H.A., Randerath K. Covalent DNA damage in tissues of cigarette smokers as determined by 32P-postlabeling assay. J. Natl Cancer Inst. 1989, 81:341-347.
37. Randerath E., Zhou G.D., Donnelly K.C., Safe S.H., Randerath K. DNA damage induced in mouse tissues by organic wood preserving waste extracts as assayed by 32P-postlabeling. Arch. Toxicol. 1996, 70:683-695.
38. Randerath E., Zhou G.D., Randerath K. Organ-specific oxidative DNA damage associated with normal birth in rats. Carcinogenesis 1997, 18:859-866.
39. Randerath K., Randerath E., Zhou G.D., Supunpong N., He L.Y., McDonald T.J., Donnelly K.C. Genotoxicity of complex PAH mixtures recovered from contaminated lake sediments as assessed by three different methods. Environ. Mol. Mutagen. 1999, 33:303-312.
40. Randerath K., Sriram P., Moorthy B., Aston J.P., Baan R.A., van den Berg P.T., Booth E.D., Watson W.P. Comparison of immunoaffinity chromatography enrichment and nuclease P1 procedures for 32P-postlabelling analysis of PAH-DNA adducts. Chem.-Biol. Interact. 1998, 110:85-102.
41. Randerath K., Zhou G.D., Randerath E., Safe S.H., Donnelly K.C. Comparative 32P-postlabeling analysis of exogenous and endogenous DNA adducts in mouse skin exposed to a wood-preserving waste extract, a complex mixture of polycyclic and polychlorinated chemicals. Environ. Mol. Mutagen. 1997, 29:372-378.
42. Reardon J.T., Sancar A. Nucleotide excision repair. Prog. Nucleic Acid Res. Mol. Biol. 2005, 79:183-235.
43. Reddy M.V., Randerath K. Nuclease P1-mediated enhancement of sensitivity of 32P-postlabeling test for structurally diverse DNA adducts. Carcinogenesis 1986, 7:1543-1551.
44. Roos W.P., Kaina B. DNA damage-induced cell death by apoptosis. Trends Mol. Med. 2006, 12:440-450.
45. Sanchez-Alonso J.A., Lopez-Aparicio P., Recio M.N., Perez-Albarsanz M.A. Polychlorinated biphenyl mixtures (Aroclors) induce apoptosis via Bcl-2, Bax and caspase-3 proteins in neuronal cell cultures. Toxicol. Lett. 2004, 153:311-326.
46. Sankaranarayanan R.M.B. Retinoids as cancer-preventive agents. IARC Sci. Publ. 1996, 139.
47. Sturgis E.M., Wei Q. Genetic susceptibility-molecular epidemiology of head and neck cancer. Curr. Opin. Oncol. 2002, 14:310-317.
48. Sun S.Y., Yue P., Chen X., Hong W.K., Lotan R. The synthetic retinoid CD437 selectively induces apoptosis in human lung cancer cells while sparing normal human lung epithelial cells. Cancer Res. 2002, 62:2430-2436.
49. Tang D., Phillips D.H., Stampfer M., Mooney L.A., Hsu Y., Cho S., Tsai W.Y., Ma J., Cole K.J., She M.N., Perera F.P. Association between carcinogen-DNA adducts in white blood cells and lung cancer risk in the physicians health study. Cancer Res. 2001, 61:6708-6712.
50. Thompson C.B. Apoptosis in the pathogenesis and treatment of disease. Science (New York, N. Y.) 1995, 267:1456-1462.
51. Tsao A.S., Liu D., Martin J., Tang X.M., Lee J.J., El-Naggar A.K., Wistuba I., Culotta K.S., Mao L., Gillenwater A., Sagesaka Y.M., Hong W.K., Papadimitrakopoulou V. Phase II randomized, placebo-controlled trial of green tea extract in patients with high-risk oral premalignant lesions. Cancer Prev. Res. (Philadelphia, Pa) 2009, 2:931-941.
52. EPA Integrated Risk Information System (IRIS) 2003, US EPA, Environmental Protection Agency, Washington, DC.
53. Uno S., Dalton T.P., Derkenne S., Curran C.P., Miller M.L., Shertzer H.G., Nebert D.W. Oral exposure to benzo[a]pyrene in the mouse: detoxication by inducible cytochrome P450 is more important than metabolic activation. Mol. Pharmacol. 2004, 65:1225-1237.
54. Uno S., Dalton T.P., Dragin N., Curran C.P., Derkenne S., Miller M.L., Shertzer H.G., Gonzalez F.J., Nebert D.W. Oral benzo[a]pyrene in Cyp1 knockout mouse lines: CYP1A1 important in detoxication, CYP1B1 metabolism required for immune damage independent of total-body burden and clearance rate. Mol. Pharmacol. 2006, 69:1103-1114.
55. Vermeulen K., Van Bockstaele D.R., Berneman Z.N. Apoptosis: mechanisms and relevance in cancer. Ann. Hematol. 2005, 84:627-639.
56. Wang L.E., Hu Z., Sturgis E.M., Spitz M.R., Strom S.S., Amos C.I., Guo Z., Qiao Y., Gillenwater A.M., Myers J.N., Clayman G.L., Weber R.S., El-Naggar A.K., Mao L., Lippman S.M., Hong W.K., Wei Q. Reduced DNA repair capacity for removing tobacco carcinogen-induced DNA adducts contributes to risk of head and neck cancer but not tumor characteristics. Clin. Cancer Res. 2010, 16:764-774.
57. Yuan J. Evolutionary conservation of a genetic pathway of programmed cell death. J. Cell. Biochem. 1996, 60:4-11.
58. Zar J.H. Biostatistical Analysis 2009, Prentice-Hall, New Jersey. Fifth edition.
59. Zhou G., Hernandez N.S., Randerath E., Randerath K. Effects of different diets and dietary restriction on perinatal endogenous DNA adducts. Time dependence of oxidative and presumptive nonoxidative lesions. Mutat. Res. 2000, 447:137-147.
60. Zhou G.D., Hernandez N.S., Randerath E., Randerath K. Acute elevation by short-term dietary restriction or food deprivation of type I I-compound levels in rat liver DNA. Nutr. Cancer 1999, 35:87-95.
61. Zhou G.D., Moorthy B., Bi J., Donnelly K.C., Randerath K. DNA adducts from alkoxyallylbenzene herb and spice constituents in cultured human (HepG2) cells. Environ. Mol. Mutagen. 2007, 48:715-721.
62. Zhou G.D., Randerath E., Randerath K. Effects of dietary transition metals on oxidative DNA lesions in neonatal rats. Mutat. Res. 2001, 479:71-79.
63. Zhou G.D., Randerath K., Donnelly K.C., Jaiswal A.K. Effects of NQO1 deficiency on levels of cyclopurines and other oxidative DNA lesions in liver and kidney of young mice. Int. J. Cancer 2004, 112:877-883.